Clinical efficacy and safety of rituximab in lupus nephritis

BACKGROUND: Long-term treatment programs with low toxicity represent a therapeutic challenge in lupus nephritis (LN). Although a therapeutic benefit of rituximab (RTX) has been reported in LN patients who have failed conventional treatment, the results are controversial. We aimed to assess the clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Zhiqing, Li, Hongyan, Zhong, Hongzhen, Zhou, Tianbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417005/
https://www.ncbi.nlm.nih.gov/pubmed/30880917
http://dx.doi.org/10.2147/DDDT.S195113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417005/
https://www.ncbi.nlm.nih.gov/pubmed/30880917
http://dx.doi.org/10.2147/DDDT.S195113

Ejemplares similares